Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.

@article{Thornburg2011DifferencesIH,
  title={Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.},
  author={Courtney D Thornburg and Agustin Calatroni and Julie Ann Panepinto},
  journal={Journal of pediatric hematology/oncology},
  year={2011},
  volume={33 4},
  pages={251-4}
}
Hydroxyurea is a safe and efficacious medication for children with sickle cell disease (SCD). Our objective was to compare health-related quality of life (HRQL) between children taking hydroxyurea and those not taking hydroxyurea. We conducted a retrospective cohort study of children with SCD who had completed the PedsQL 4.0 at Duke University Medical Center or the Midwest Sickle Cell Center. Our primary outcome was HRQL in children receiving hydroxyurea therapy compared with those not… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…